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Inflammatory Bowel Disease (IBD) describes a group of conditions that includes Crohn’s disease and ulcerative colitis. Unlike some
chronic conditions, to a greater or lesser extent, IBD is hidden from or invisible to others which enables concealment of the
condition, especially when stigma is associated with the condition. Concealment or nondisclosure allows a means of identity
management. Disclosure of a chronic condition is not a single event, and it is dependent on many factors. There is little
literature that specifically addresses stigma and/or disclosure in relation to children and young people with IBD. An in-depth
qualitative study was undertaken, framed by Interpretive Description and using interviews, friendship maps, and photographs
within a participatory framework. Public and patient involvement and engagement (PPIE) was undertaken throughout
(inception to dissemination) the study. Young people aged 14-25 years with IBD who had participated in the survey phase of
the larger study self-selected to participate in interviews that focused broadly on friendship and feelings of social connectedness.
Data were analysed using an iterative, interpretive approach. Preliminary themes were developed and these were explored
further, and then tentative theoretical connections about friendship were developed. One superordinate theme focused on
disclosure. Thirty-one young people (16 males, 15 females, mean age 18.7 years; 24 Crohn’s, 7 colitis) participated in the
interviews (of these, five created friendship maps and six utilised photographs). Three discrete, but interlinked, themes were
generated, revealing young people’s experiences of disclosure: to tell or not to tell; controlling the flow: the who, when, what,
and how of telling; and reactions and responses to telling: anticipated and actual. Decisions about telling friends about having
IBD are challenging for many young people. Having control over disclosure is not always possible, and the potential
consequences can feel risky. However, most young people had positive experiences of disclosure and gained support from
friends and romantic partners. Most young people downplayed the seriousness of their IBD, revealing some facets of their
condition, aiming to sustain their self-identity. Only one young person had been given professional support to disclose.
Provision of support and opportunities to discuss whether, when, who, and how to tell friends and what the risks and benefits
may be is something that could be woven into an ongoing and wider person-centred dialogue between young people and health
professionals within routine clinic visits.
1. Introduction
Inflammatory Bowel Disease (IBD) describes a group of con-
ditions that include Crohn’s disease and ulcerative colitis. Up
to 25% of IBD starts in childhood or adolescence [1]. IBD is a
“chronic, heterogeneous, relapsing and remitting condition
primarily as a consequence of inflammation within the bowel
lumen” [2]. This group of conditions is characterised by
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uncertainty, unpredictability, and the intrusiveness of symp-
toms and flare-ups [3, 4]; common symptoms are diarrhoea,
abdominal pain, weight loss, blood in the stools, and fatigue
[5]. Both IBD and its associated medical management can
severely negatively impact psychosocial functioning and
health-related quality of life [6, 7] and increase anxiety and
stress [8], loneliness and depression [9, 10], and other psychi-
atric disorders [11].
Unlike some chronic conditions, to a greater or lesser
extent, IBD lacks “surface descriptions” [12]; for the most
part, it is hidden from or invisible to others [13], which
enables concealment of the condition. People with a hidden
condition may decide to conceal it from friends and family
and from key stakeholders in their lives such as teachers
and employers as a means of identity management [14]. Such
concealment helps sustain a sense of self as a “normal” per-
son [15] and avoids negative biographical disruptions [14,
16] such as the stigma and tarnished identity of being known
by the bodily disruptions and eruptions of IBD [13]. Young
people have to manage those challenges to their identity as
they become “emerging adults” [17], a key turning point in
their development of self-identity [18].
Stigma is socially constructed, intraindividual, and exter-
nal [19] and can be defined by characteristics including label-
ling, separation, stereotyping, status loss, controllability,
discrimination, and negative attributions/blame [20, 21].
There are different types of stigma (Table 1). Nondisclosure
(deciding not to tell other people) of this aspect of their iden-
tity is common among children with IBD [22] because of the
ongoing societal taboo about bowel conditions [18]. Disclo-
sure is not a single event [23]: it is a dynamic, selective, com-
plex, context-dependent, and nonlinear progressive journey
drawing on multiple strategies [15, 24]; the extent of disclo-
sure can range from partial to full(er) [25]. Who and what
a person decides to share about their condition is related to
their adjustment to their diagnosis and altered identity [14]
and their experiences in different situations such as school,
university, or work [26] and their transitions during their life
course [13, 24, 27].
Decisions about disclosure are rarely taken lightly
because disclosure can be risky [30]. Negative experiences
of disclosure can result in psychological distress and poorer
quality of life [31]. However, nondisclosure may result in
the person experiencing feelings of isolation and psychologi-
cal distress [26, 32]. The reasons for choosing to disclose are
many and varied but include a need for impression manage-
ment [25], a desire for social support, the wish to promote
physical and mental well-being, and the wish to share this
aspect of their identity but be in control of that sharing [4,
32]. Other reasons include the desire to educate other people
about the condition, support others, and reduce stigma [13];
these reasons are often presented in public campaigns about
IBD, such as “it takes guts” (https://www.ittakesguts.org.uk).
Disclosure has been categorised in many different ways,
often reflecting the degree of control that the person has over
the process. Revelatory or forced disclosure occurs when a
degree of openness about their condition is forced on the per-
son regardless of their level of preparedness or their desire to
reveal this aspect of their identity [33, 34]. Protective or pre-
ventive disclosure is usually selective [34], with the person
purposefully disclosing the condition with the aim of gaining
control over the social consequences [33]; it may be sponta-
neous or prompted by a person’s enquiry or an unfolding sit-
uation [25]. The type and extent of information shared
during an episode or episodes of disclosure reflect the pur-
pose of the disclosure but are generally informative about
the condition and its consequences [25]; it is often limited
and bounded by the need to retain control over privacy and
sense of self [13].
Although there is a body of evidence addressing the con-
cepts of stigma and disclosure, most is adult-oriented and/or
focused on conditions such as epilepsy and cystic fibrosis or
more broadly on chronic conditions. There is little literature
[18, 25, 35] that specifically addresses stigma and/or disclo-
sure in relation to children and young people with IBD.
The current paper is aimed at contributing to knowledge in
this area by presenting qualitative findings on disclosure,
generated as part of a large exploratory, sequential mixed
method study that explored the impact of IBD on the social
relationships and psychological functioning of young people
ages 14-25 years, with the condition.
2. Study Design
2.1. Aim of the Study. The aim of the larger mixed method
study —survey (Phase 1) and interviews (Phase 2)—was to
explore friendships and feelings of social connectedness
among young people with IBD. The analyses presented in
this paper are specifically aimed at exploring disclosure and
arise from Phase 2 (interviews).
2.2. Overview of the Data Collection Methods. The approach
used for this in-depth qualitative study was Interpretive
Description [36] (a grounded approach that is aimed at
Table 1: Types of stigma (developed from [19, 28, 29]).
Type of stigma Description
Anticipated Expectation by the person with condition that people will stigmatise them
Perceived or felt Degree to which person perceives stigma directed at them from others
Internalised How much the person believes that discrimination against them is deserved
Enacted Social discrimination by people towards those with condition
Associative or affiliate Stigma experienced because of connection with a stigmatised person
Kinship Being or feeling stigmatised by members of family
Cultural or external Degree to which society/culture person living in devalues person’s condition
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answering complex questions about the experience of a con-
dition through articulating patterns and themes generated by
interpretation of qualitative data) [37, 38]. Data were col-
lected using interviews, friendship maps, and photographs
within a participatory framework.
2.3. e-Advisory Group and Wider Engagement with Young
People. Our core e-Advisory Group (n = 10 young people,
15-26 years old), plus our targeted engagement with young
people, parents, and professionals, ensured we were informed
and grounded throughout the study. Our engagement with
stakeholders provided insight and advice about phrasing of
questions within interviews and the potential burden of the
surveys and the construction of the findings. This engage-
ment was key to the development of the animation we cre-
ated to share the young people’s experiences of disclosure
and disseminate findings.
2.4. Sampling, Inclusion Criteria, Recruitment, and Settings.
Convenience sampling was used in Phase 1 to recruit young
people via invitation letters sent out from hospital clinics,
to participate in a survey; recruited young people were able
to self-select to participate in the qualitative interview phase
of the study. Young people were eligible to participate in this
phase of the study if they were aged 14-25 years, had been
diagnosed with IBD for at least 3 months, and had completed
a Phase 1 survey in either of the two University hospital set-
tings (one children’s hospital and one adult hospital) in the
North West of England, United Kingdom.
Recruitment for this phase occurred through young peo-
ple self-identifying at the end of the Phase 1 survey if they
were interested in taking part in an interview at their next
clinic/hospital visit (providing this fell within the data collec-
tion window). The young people who were interested were
asked to complete an “expression of interest” form which
included their preferred means of being contacted (text,
phone, or email) which we used to contact them 2-3 weeks
before their scheduled clinic/hospital visit (usually this was
2-3 months following survey completion); if they responded
expressing interest, information sheets were sent by post or
email. Agreement to meet them at their clinic/hospital visit
was made by text/email or phone; consent/assent or a deci-
sion to not participate was finalised at that visit and the inter-
view undertaken, as appropriate. Of those who participated
in Phase 1 (n = 131), 59 provided contact details and were
willing to participate in Phase 2, but of these, 28 were unable
to participate either due to them not having a scheduled
clinic appointment within the timescale of the study, not
turning up for their clinic appointment, or researcher
unavailability for their specific clinic.
2.5. Methods. We utilised three linked data collection
methods to provide the young people with a range of differ-
ent modes of expression because we appreciated that solely
asking young people to talk about friendships and IBD might
be restricting. We used conversational interviews, friendship
maps, and photographs to allow for the generation of both
verbal and visual data, with the intention that visual data
would trigger conversations and empower young people to
have direct control over their interaction with the researcher.
The values that underpinned the whole of this study were
person-centred and accounted for the sensitivity of the topics
we would be discussing; it is our firm belief that young people
with IBD are experts of their own experience.
2.5.1. Conversational Face-to-Face Interviews. We adopted a
conversational and appreciative approach to the interviews,
aiming to ensure that the young people felt comfortable
sharing their experiences of friendship and the impact—if
any—that IBD had had on those friendships and friendship
networks. A sensitively and carefully prepared topic guide
with prompts was developed with guidance from young peo-
ple, the literature, and researcher experience and in collabo-
ration with experts from clinical practice. This guide was
aimed at helping the conversation flow. After the first few
interviews, we further refined the questions and added some
more prompts, reflecting our learning about how the ques-
tions worked with the young people in these clinical settings
(see supplementary file for revised interview guide (available
here)). This also helped to achieve a degree of consistency of
questioning and approach across the interviewers. For the
interviews that were augmented by the maps and photo-
graphs (see later), these materials were woven into the
dialogue.
The interviews were conducted face-to-face by four
members of the research team who had no responsibility
for the young person’s care and who were not known to the
participants unless they had met them briefly when conduct-
ing the earlier survey part of the study. The interviewers were
all university-based researchers with expertise in interview-
ing children and young people; two had backgrounds in
children’s nursing, one in psychology and one in education.
Interviews were conducted in a private room or quiet setting
in the clinic/ward during a scheduled and routine visit
between October 2018 and April 2019. All interviews were
audio-recorded with the young person’s permission, and
these recordings were then fully transcribed.
2.5.2. Friendship Maps. We asked young people to create a
map of their friendships which illustrated who their friends
were, how close and strong those friendship ties were, where
those friends were situated (e.g., school, clubs), and any losses
or overlaps in friendship groups. Typically, short, broad lines
reflect close friendships whilst longer, thin lines reflect more
tenuous friendships, although explanation by the young per-
son is key to interpretation. The maps could be created prior
to or during the interview. These maps could be simple
labelled “spider diagrams” or more complex maps including
information such as how long they had been friends, where
they had met, what made them good friends, and whether
or not there had been challenges to these friendships. This
approach was based on a participatory mapping technique
(PMT) [39, 40], which allows the young person’s gaze to be
on the map [41] rather than necessarily having to have
eye-to-eye contact with the researcher. PMT facilitates a
form of reflective sense-making during the creation of the
map, allowing the young person time to think through the
map they are making and what they wish to share. Being
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able to revise and refine their maps based on the reflexive
dialogue between the participant and the researcher created
the opportunities for the process to support emotional
reflexivity [42].
2.5.3. Photographs. The use of photographs drew on the
photoelicitation technique [43–46] as a means of providing
young people with a visual image that they had specifically
selected to trigger the conversation and which summed up
an aspect of friendship they wished to share.
2.6. Ethics Approval. The study was approved by NorthWest-
Liverpool East Research Ethics Committee (18/NW/0178)
and research ethics committees at Edge Hill University and
University of Manchester. Alongside all of the usual care
and attention paid to best ethics practice, we developed a
“Distress Protocol” in collaboration with the clinical teams,
to provide a clear pathway of how we would manage a young
person who we believed was distressed either by engagement
in the study or who revealed distress/anxiety to us that we felt
required support from the clinical team.
2.7. Data Analysis. We used an iterative, interpretive
approach to data analysis aligned to Interpretive Description
[36]. We initially focused on each young person’s dataset
(interview, friendship map, or photographs) with each inter-
viewer analysing the interviews they had personally under-
taken; two researchers (BC and AR-S) worked across all
interviews. We initially developed preliminary themes,
explored meanings, and developed tentative theoretical con-
nections about disclosure; these were brought together for
discussion within the team and challenged and refined. A
final consensus set of superordinate themes was generated.
3. Findings
3.1. Demographics.We interviewed 31 of the 131 young peo-
ple who participated in the Phase 1 survey. Of these 31, five
created friendship maps and six utilised photographs they
had taken themselves within their interviews (two gave per-
mission for their photographs to be part of the dataset).
The young people who chose to use the additional methods
found it helped them talk about issues of importance to them,
as it helped them think through the connections and support
systems around them. Even when the friendship maps were
apparently quite “scribbled and basic” (see supplementary
file for example of friendship map (available here)), they
acted as starting points and anchors for conversations of
importance to them, as did the photographs they shared.
16 participants were males and 15 were females: age at
study—mean 18.7 years, range 14-25 years; age at diagno-
sis—mean 14.4 years, range 8-23 years. Most (n = 21) had
been diagnosed 5 years or fewer. Twenty-four young people
had Crohn’s disease (two had stomas) and 7 had colitis (6
with ulcerative colitis and 1 with IBD-unclassified). Seven-
teen were classified as being in remission, 9 mild, and 5 mod-
erate disease severity and were measured using the
appropriate index used in the clinical setting; these were Pae-
diatric Ulcerative Colitis Activity Index (PUCAI), Simple
Clinical Colitis Activity Index (SSCAI), Harvey-Bradshaw
Index (HB Index), and weighted Paediatric Crohn’s Disease
Activity Index (wPCDAI) (see Table 2).
The findings presented in this paper focus on disclosure,
and this topic was discussed in most detail by the older par-
ticipants. The findings reveal that the young people with
IBD needed a sense of control, albeit illusory and tenuous
at times, over the processes linked to disclosure of their con-
dition. Three discrete, but interlinked, themes were gener-
ated, revealing young people’s experiences of disclosure:
(i) To tell or not to tell
(ii) Controlling the flow: the who, when, what, and how
of telling
(iii) Reactions and responses to telling: anticipated and
actual
The quotations are presented with key information:
interview number (e.g., ID2); gender and age (F12); and con-
dition, e.g., CD or UC or IC.
3.2. To Tell or Not to Tell? At the time of interview, all of the
young people had told at least one of their friends something
about their condition. For the most part, decisions to tell or
not to tell their friends were active, deliberate, and conscious.
However, sometimes young people had little or no control
because disclosure was forced upon them by particular cir-
cumstances, often resulting from treatment and interven-
tions making their condition visible to others. One young
man recalled how friends found out when they saw him
“drinking this weird pink thing out of a water bottle” (ID7,
M14, CD), and disclosure occurred for a young woman as
result of her “school [making] a massive deal….[about] the
gastric tube” (ID1, F16, CD).
Where young people were able to have control, reasons for
not telling related to the desire for “privacy” (ID30, M24, CD)
and not wanting “anyone else to know” (ID6, F16, CD). Some
decisions not to tell were perhaps less deliberate andmore pas-
sive; some of the young people simply did not see their condi-
tion as something to tell their friends about; “it was just a thing
we didn’t talk about” (ID1, F16, CD). The “awkwardness of
the conversation” (ID12, F23, CD) and the difficulty of
explaining the condition made conversations tricky:
It’s hard for to explain colitis, it’s the hardest thing in the
world… But still now after so many years [to explain] you
got ulcerative colitis … it’s not just an upset tummy, it’s the
whole body. And I have lots more complications and I’m on
medication. (ID9, F21, UC)
Embarrassment about the condition was a factor that
constrained disclosure. A young woman explained “it’s not
that I can’t tell people, it’s that I choose not to because of
my own emotions, feelings in general” (ID21, F20, CD),
and a young man recalled his embarrassment:
I think having to say it’s colitis, I cannot go out because
something might happen... It’s not something I want to say.
(ID10, M23 UC)
Other young people reflected that telling friends some-
times involved challenging conversations that they were not
always ready for or “in the mood to have” (ID25, M21, CD).
Choosing to tell friends was often a pragmatic decision to
be open about their condition, with some young people
deciding that “there’s no point in trying to hide it” (ID24,
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M20, CD) or feeling ready to respond openly to an enquiry
from friends, “If people ask, I tell them” (ID1, F16, CD), or
being prompted to reveal more about their condition at par-
ticular times such as during “flare-up” when it was felt
important to “mention it to people like my friends” (ID11,
F21, UC).
The young people who talked about romantic partners,
were mostly 18 years or older and more males than females
talked about these relationships. One of the younger girls
explained that she was “not really bothered to be honest
about boyfriends” (ID17, F15, CD). The young people
revealed that the decision to disclose to a romantic partner
required particular deliberation; the actual or potential phys-
icality, intimacy, and closeness of their relationships created
additional significance. Decision-making about disclosing
to actual or potential romantic partners often shifted as the
young people got older and/or became more confident about
their condition. One young man reflected that his openness
grew as he became more relaxed about telling, “I didn’t really
tell them [at first] but the last two years every girl I’ve been
with I’ve told them” (ID30, M24, CD).
One young woman explained that her partner “knows
everything that is wrong” (ID12, F23, CD). Disclosure was
not just limited to what was currently happening but what
might happen; one young woman explained she had told
her partner about potential IBD-related issues that could
arise, such as the need for a stoma, noting “I have had long
conversations with him [about possibly having] a colostomy
bag” (ID28, F19, CD).
Apart from one young person who had received guidance
from her psychologist, none of the young people talked of
having received any support from professionals about
disclosure.
3.3. Controlling the Flow: TheWho,When,What, and How of
Telling. Apart from wanting control over whether they
Table 2: Key demographics of participants.
ID Gender Age yrs (age diagnosed) Diagnosis Surgery (stoma) Disease activity1,2,3,4
2 Female 14 (11) Crohn’s No Mild4
4 Male 14 (13) Crohn’s No Remission4
7 Male 14 (12) Crohn’s No Mild4
3 Male 15 (9) Crohn’s Yes (stoma) Remission4
5 Male 15 (9) Crohn’s Yes Mild4
16 Male 15 (11) Crohn’s No Remission4
17 Female 15 (12) Crohn’s No Moderate4
27 Female 15 (11) Crohn’s No Remission4
1 Female 16 (11) Crohn’s No Mild4
6 Female 16 (13) Crohn’s No Remission4
14 Female 16 (10) Crohn’s Yes Remission4
15 Male 16 (15) Crohn’s No Remission4
28 Female 19 (8) Crohn’s Yes Remission3
21 Female 20 (19) Crohn’s No Remission3
24 Male 20 (12) Crohn’s No Mild3
31 Female 20 (12) Crohn’s Yes Moderate3
23 Male 21 (14) Crohn’s No Remission3
25 Male 21 (20) Crohn’s Yes (stoma) Remission3
19 Male 22 (21) Crohn’s Yes Remission3
12 Female 23 (15) Crohn’s Yes Mild3
22 Male 24 (16) Crohn’s No Moderate3
30 Male 24 (19) Crohn’s No Remission3
18 Female 25 (23) Crohn’s Yes Mild3
29 Female 25 (23) Crohn’s Yes Mild3
13 Female 16 (15) Ulcerative colitis No Remission1
26 Male 16 (12) Ulcerative colitis No Mild1
9 Female 21 (8) Ulcerative colitis No Remission2
11 Female 21 (16) Ulcerative colitis No Moderate2
10 Male 23 (20) Ulcerative colitis No Moderate2
20 Male 24 (22) Ulcerative colitis No Remission2
8 Male 14 (12) Unclassified colitis No Remission1
Key: 1Paediatric Ulcerative Colitis Activity Index (PUCAI); 2Simple Clinical Colitis Activity Index (SSCAI); 3Harvey-Bradshaw Index (HB Index); 4weighted
Paediatric Crohn’s Disease Activity Index (wPCDAI).
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disclosed their condition, the young people wanted control
over who they told, when they told, what they told, and
how they told their friends about their condition.
The decision to tell was closely linked with the decision
about who to tell, and most of the young people were selec-
tive about which of their friends they told; it was sometimes
seen as a risky business. They were clear that their IBD was
something they “[did not] want everyone to know [about]”
(ID6, F16, CD) and that telling was done on a need to know
basis; often this selection was based on trust and involved
“sussing out who to trust” (ID21, F20, CD) and often resulted
in selecting people they considered to be “close friends”
(ID30, M24, CD). However, other young people were not
selective about who they told, “I told everyone I didn’t shy
away from it” (ID20, M24, UC) not least because “there’s
nothing I can do about it [Crohn’s]” (ID24, M20, CD). Some
were not selective about what they shared:
I do not mind telling them how often I go to the bathroom
either. I have no restrictions. If people want to know, they can.
(ID29, F25, CD)
When the young people were in control of timing dis-
closure to their friends, typically, this was not immediately
after diagnosis; some young people chose to take months
or until something triggered telling and others took much
longer before telling. One young man “took about two
years to even tell the group and I’ve only told four people”
(ID30, M24, CD). Another young person talked of delaying
disclosing aspects of their condition even to friends who
knew their diagnosis explaining that “if something bad
has happened, I will tell a few months afterwards” (ID11,
F21, UC). Some did not see that there was an urgency to
telling:
I’m fine with telling friends about it but in a way it’s not
one of those things that they really care about or in fact I really
care about telling them, often I deal with it myself and with my
family. (ID3, M15, CD)
The content of what young people disclosed varied
depending on factors such as their confidence in explaining
the condition, the level of detail they wanted to reveal, and
the purpose behind telling their friends.
Many of the young people reported that they found it
“kind of like hard to explain” their condition in a way that
their friends would understand, especially when they were
unaware of the level of knowledge of or misconceptions
about the condition their friends might have. Typically, they
avoided going “into complete detail” (ID30, M24, CD) about
their condition because they “don’t like to make a big thing
out of it” (ID6, F16, CD). They often aimed to elicit an undra-
matic response from their friends:
Yeah, I just told them the story of what happened really
and they were just like, it’s good that you cope with it. (ID2,
F14, CD)
Many of the descriptions downplayed the seriousness of
the condition and/or the severity of symptoms, and some
talked of how they “just laughed off” (ID 19, M22, CD) or
“make a joke about it” (ID11, F21, UC) or masked even quite
troubling symptoms as they “didn’t want to make a fuss…..
be defined by it” (ID10, M23, UC). The language chosen to
describe their condition was often carefully selected “I tend
to just use generic terms, "My stomach’s not feeling very well
or things like that" (ID24, M20, CD).
The reason why the young people were disclosing
impacted the content of what they told their friends. Some
were simply explaining that they had the condition, some
disclosed as a means of gaining support, and others had a
more educative focus, wanting to their friends to better
understand what their condition encompassed:
They [friends] associate you with wanting to go to the toi-
let, and I’m like, ‘No, it’s not always about that’. There’s a lot
of different aspects, like, it goes from your mouth, like, to your
bum, it goes all the way down, and so it’s just trying to get that
across. (ID18, F25, CD)
However, for some young people, the reason for disclo-
sure was to warn potential friends of what they might be get-
ting into, with one recently diagnosed young woman
suggesting that disclosure allowed their friends to “decide
whether or not it’s worth them investing time [in me]”
(ID21, F20, CD).
Having decided who and what to tell, young people had
to decide how to tell their friends. The “how” of telling
involved considering whether to tell face-to-face or remotely
as well as issues such as where to tell. Few young people
talked of having guidance or information from professionals.
Only one young person talked about gaining professional
support about how to disclose, “I started seeing my psychol-
ogist and then we came up with ideas on how to tell them”
(ID17, F15, CD). Most young people told their friends face-
to-face, although some told remotely “When they [doctors]
said ‘You’ve got Crohn’s’ - I texted them [friend]” and the
young person who had spoken to her psychologist “made a
snap chat group so I could tell them all at once rather than
doing it separately and still having to say the same thing”
(ID17, F15, CD). Others used a mix of face-to-face and the
Internet, relying on the Internet to fill in gaps of understand-
ing, “It’s when people say what is that and I’m like, ok, google
it, yeah” (ID21, F20, CD).
3.4. Reactions and Responses to Telling: Anticipated and
Actual. Decisions about disclosure were not without conse-
quences, and although for most of the young people disclosure
was not a negative experience, some young people’s fears
about being rejected or seen as different were fulfilled. One
young person explained that “some people think that because
it’s a disease, Crohn’s - they say ‘Oh my God can I catch it off
you?’” (ID1, F16, CD). Some young people recalled their initial
overriding anxiety about talking about their condition, even if
they were unsure why they were anxious, explaining “so I
didn’t want to speak to anyone I didn’t know... I was just con-
cerned about like… I don’t know really” (ID8, M14, IC).
Some young people were concerned that even if
responses were not overtly negative, their friends might be
thinking about them negatively, “they don’t necessarily have
to react badly, but if I think that they’re thinking something
then…” (ID12, F23, CD). Others were worried about being
pitied, “can’t be bothered with [pity]” (ID28, F19, CD) or
their condition becoming the focus of attention:
I’ve got a colostomy bag – it’ll turn into a discussion all
about that and, the sort of, the fear is always… I do not want
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the sympathy... I feel getting sympathy from people and people
sort of viewing me as ‘different’ or ‘not well’ when in myself I
am well, …..could, in my view, make them maybe see less of
me as a person. (ID25, M21,CD)
Mostly, young people were surprised by the support they
gained from friends, even when they had been expecting
rejection, “I was like, ‘I’ve got this’ and they were like, ‘Oh’
and supportive of me and stuff” (ID, 26, M16, UC). Another
young man talked of the support he gained from a friend who
also has a chronic condition.
Like he’s got diabetes and stuff so he has to be careful with
drinking and stuff, that sort of thing. And he said he knows
someone who’s got colitis and stuff. (ID10, M23 UC)
The ability to “open up” to supportive friends who knew
and understood was described as being “quite heartening”
with young people knowing “I can tell them stuff in private
and they wouldn’t tell people or judge me for it” (ID13,
F16, UC).
Several young people talked of the importance of their
friends knowing about their condition as it helped in “forging
friendships” and allowed them to “feel a lot closer to someone
if I know that they know exactly what I’m going through”
(ID20, M24, UC). Another young person found that their
condition created unexpected connections:
People sort of got along with me even better because I prob-
ably was feeling a bit low and probably come out with more
outrageous [funny] stuff, so the Crohn’s business…like having
to go for a colonoscopy, having to go for an endoscopy…, silly
stories to tell people. (ID22, M21, CD)
Some people had been selective about who they had told,
and that had led to some awkward situations when “some
people know things that others don’t…. it gets a bit awkward
then because you’ve got to like, explain” (ID25, M21, CD).
Other young people were much more sanguine about the
potential or actual loss of friends as a result of disclosing their
condition, explaining they had been “lucky,” as mostly their
friends had been “relatively accepting apart from a few who
I’ve just cut out of my life because I thought they’re not worth
being friends with” (ID28, F19, CD).
In the context of romantic relationships, the stakes were
often seen to be higher and young people balanced the anxi-
ety of disclosing with the consequences of unexpectedly can-
celling dates due to illness:
I do not tell them [girlfriends] at first but if it’s like the
third date and I want to keep seeing them ….. I just want to
kind of just tell them and for them to understand because there
can be times where I cancel a date at the last minute. (ID30,
M24, CD)
Other young people acknowledged that sharing informa-
tion was more problematic for them than their partners with
one youngman explaining how he “kind of like tiptoe around
and things like that especially if, you know, I’m having toilet
troubles” (ID24, M20, CD) whereas his partner is “OK”
about it.
4. Discussion
Within the current study, issues related to disclosure featured
in most of the stories shared by the young people. Three key
processes were presented in the findings: whether or not to
tell their friends; who, when, what, and how to tell; and the
responses to telling. Each of those aspects was closely inter-
linked. For example, the degree of confidence or concern
about how friends might respond to being told impacted
whether young people decided to disclose and to whom they
disclosed. This discussion draws on findings about disclosure
from both IBD-specific and other chronic conditions and
spans literature addressing children and adults. Little of this
literature focuses exclusively on disclosure to friends.
Disclosure to friends should perhaps be better described
as a series of disclosures prompted by changes in the young
person’s life that generate new opportunities to make friends
such as changing school and moving to college or university
or into the workplace. As reported elsewhere, disclosure was
clearly a dynamic, complex, and context-dependent process;
it was not a one-off event [23, 24, 27, 30–32]. Young people’s
desire for control of disclosure was evident in relation to each
of the key processes. However, disclosure, much like their
condition, was not something over which they had full con-
trol. Across this diverse sample (age at diagnosis, years of liv-
ing with condition, age at interview, and gender), little
difference was noted between the young men and the young
women in terms of who they told (e.g., same or different sex
friends), when, or how they told.
IBD is uncertain, unpredictable, and intrusive [3, 4]. Our
findings support other work on IBD [25] and conditions such
as epilepsy [23] that disclosure is a process laced with uncer-
tainty and unpredictability [18, 25] particularly in relation to
the potential intrusive consequences. In our study, few young
people talked of having guidance, support, or information
from professionals or accessing resources to help them pre-
pare for or deal with what was initially perceived as being
the risky business of disclosure. Some form of personal dis-
closure plan might be of value; such an approach has been
shown to be useful for disclosure to employers by young peo-
ple with mental illness [47]. “Practice telling” or rehearsal has
been shown to be helpful for young people with epilepsy [15].
Individuals had different disclosure experiences; some more
positive than others [47]. All the young people in the current
study had been living with a diagnosis of IBD for at least 3
months, and all of them had disclosed to at least one friend.
Young people decided to disclose when the time felt right
for them, and as noted elsewhere, it was part of their “pro-
cessing journey” [15] and the particular situation or setting
[30] and life stage [24]. Fundamentally, this reflected their
sense of self or self-identity [17] and their level of comfort
in disclosing, as also seen in disclosure by young people with
epilepsy [15]. As noted elsewhere, for some young people,
disclosure was a “prominent issue” [48]; for others, either
the prominence had faded or it was less of an issue for them.
Either way, it would seem useful if guidance was offered in
relation to how to tell.
We found that there were different reasons for nondisclo-
sure, and these were similar to findings from other studies on
disclosure: the young people in the current study were also
fearful of being seen as “less of a person” [15] or being per-
ceived as different or tarnished [4, 13], pitied [26], rejected
[32, 34], or teased [22]. Others were concerned about being
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morally judged by others [18] or wanted to keep knowledge
of their condition private [13]. Unlike some conditions, the
invisibility of IBD allowed the young people to try and sus-
tain their preillness identity, positioning themselves as
healthy [49], thus avoiding the potential labelling, discrimi-
nation, and loss of status and control that can occur with a
stigmatising illness [21, 22].
Many of the young people shared, even if in passing, the
potential for their illness to stigmatise. The influence of cul-
tural stigma was evident in that the young people were aware
that bowel conditions or talking about bowels is still some-
thing of a societal taboo [18]. This sets up the context in
which some young people talked of an expectation that
friends would or might stigmatise them (anticipated stigma)
[19]. Others talked of concerns that their friends might feel
stigmatised because of their connection with them (associa-
tive stigma) [19]. Anticipated stigma became enacted stigma
for some young people when established friendships or
friendship networks were damaged or lost by disclosure, as
seen elsewhere [14]. Unexpected responses included friends
worrying if the condition was catching; contagion is also
associated with stigma (associative stigma). Although some
young people were concerned to a lesser or greater degree
about their condition tarnishing their identity [13], none
of them talked in a way that suggested they accepted that
discrimination against them would be deserved (interna-
lised stigma). When stigma was felt, anticipated, or
enacted, the response was to perceive that any labelling
or damage to friendships reflected a weakness or shallow-
ness in the person or people doing the labelling or cutting
friendship ties.
For the most part, the young people in the current study
took the decision to disclose seriously, and that has also been
reported by other young people with IBD [35]. Most exer-
cised a cautious and deliberate approach to the process, and
as in other studies, they weighed the potential benefits and
costs [24] and were selective [42] about which friend or
friends they talked to about their condition. They acknowl-
edged that not everyone needed to know [15] and were pur-
posive about what they shared. Findings from other studies
support our own conclusions that the young people initially
tended to select close friends whom they thought they could
trust [25, 34]; however, sometimes they were disappointed by
their friends’ reactions to their disclosure.
Reasons for telling their friends varied within the current
sample. Often, telling friends reflected a desire to be honest or
open [4] with their friends, to let them know what was hap-
pening or explain their absences or changes in behaviour
[13], and those reasons were similar regardless of whether
they were disclosing to everyday friends or potential/actual
romantic friends or partners. This form of protective [30,
50] or preventive disclosure [33] is evident in other chronic
conditions such as epilepsy [15, 23, 34], where the desire to
disclose is informed by the need to establish control over per-
ceived negative social consequences such as rejection or
being stigmatised. In addition, that control can sustain their
self-identity and be a form of impression management [14,
25]. A minority of young people in the current study were
more open about their condition with their friends, appar-
ently unconcerned about the potential consequences or
unbothered about dealing with them if they arose.
Some young people experienced forced and unplanned
[34, 51] disclosure, a situation in which they had little or no
control as something or someone else had revealed their con-
dition, either intentionally or unintentionally [33, 34]. Those
young people had little or no time to prepare themselves for
telling and talked of feeling exposed by this. In these situa-
tions, their ability to conceal their IBD, because of its lack
of “surface descriptions” [12, 25] failed, and their IBD was
made public. In the current study, the intentional broadcast-
ing [34, 51] of the young person’s condition by a school at
morning assembly was almost certainly done with the best
of motives, but this was not the young person’s perception.
As seen in other studies, disclosure conversations about
their condition with friends ranged from being easy to awk-
ward or challenging [25], partly because of the uncertainty
[25] about, and unpredictability of, their friends’ initial and
ongoing responses. The decisions about what and how to
share reflected the young person’s experience in disclosure
and what they had learned in the process both about them-
selves and other people’s reactions and where they were on
their life journey. As they gained experience in telling, they
had a clearer idea of what they wanted to say and the extent
of disclosure. As seen elsewhere, perceived risks were some-
what higher when disclosing to an actual/potential romantic
friend or if the relationship was or likely to be intimate [52],
but in these cases, it was pragmatically often impossible not
to disclose [26]; the salience of the condition is raised in such
situations [53]. Typically, the young people tended towards
partial rather than full disclosure [25], revealing generic, less
embarrassing aspects that were likely to elicit the least dra-
matic responses and which were less awkward to share. As
seen elsewhere, the seriousness of their condition was often
downplayed [13]; this was achieved by using simple language
and explanations. Even when telling, boundaries were in
play; other work with children with IBD notes their tendency
to restrict disclosure to limited information about the condi-
tion [25]. Limiting explanations reflected a desire to both
protect themselves and shelter their friends from too much
detail—a sense of the more you tell, the more you risk. Typ-
ically, the young people told their friends face-to-face, the
approach most usually reported for disclosure; however, as
seen in other studies, some used social media [17, 26].
Although some authors suggest that a key purpose of dis-
closure is to elicit support [13, 32], this was less overt in this
study. However, the support of friends was often a very pos-
itive outcome of having the courage to tell them about their
condition, as friends were able to accommodate the young
person’s needs and “be there” for them [14].
Despite the challenges associated with disclosure, most of
the young people in the current study managed this without
professional advice or support [52]; little literature addresses
this key issue. Most were also apparently unaware of the
resources that might have been helpful. However, most IBD
resources are not focused on disclosure and young people,
although CCUK’s recently developed Talking Toolkit
(https://www.ittakesguts.org.uk/talk/talking-toolkit) is likely
to be of value. Indeed, findings from an experimental study
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on stigma and IBD found a positive correlation between an
increase in knowledge of IBD and reduced stigma [29]. The
young people in our study and the members of our e-
advisory group recognised the need for a resource developed
from their experiences and ideas. The “Telling My Friends”
resource (a two-minute animation and information sheets
aimed at supporting young people in telling their friends and
at helping their friends support them) is the end result of
collaborative working (https://ehu.ac.uk/CrohnsorColitis).
Our hope is that our contribution to increasing awareness
of IBD may help to reduce the stigma and taboo associated
with the condition.
4.1. Limitations of the Study. The sample for this qualitative
phase of the study was recruited using convenience sampling
from Phase 1 and from two hospitals within the same city
and was not ethnically diverse, with most being White. Thus,
our findings may not be representative of the wider popula-
tion. In addition, the views of young people with colitis were
less present than those with a diagnosis of Crohn’s disease.
Those with severe disease activity chose not to participate
in this phase.
5. Conclusion
The findings outlined in this paper are part of a larger study
addressing friendships and social connection: disclosure was
a key aspect that the young people talked about. It seems clear
that decisions about telling friends about having IBD are
challenging for many young people. Provision of support
and opportunities to discuss whether, when, who, and how
to tell friends and what the risks and benefits may be is
something that could be woven into an ongoing and wider
person-centred dialogue between young people and health
professionals within routine clinic visits. The young person’s
IBD nurse may have a particularly important role to play
here in terms of their ongoing engagement with them. This
dialogue could focus not only on those things of direct rele-
vance to the clinician’s clinical management of the young
person’s condition but also on those things linked to their
condition that matter to the young person, such as disclosure.
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